CEO, Neurala Biosciences
| Role | Organisation | Sources |
|---|---|---|
| Head of the Psychedelics Research and Therapeutics Unit | University of Melbourne | LaunchVic, Forbes Australia |
| Co-founder and co-CEO | Psychae Therapeutics | Forbes Australia, SmartCompany |
| CEO | Neurala Biosciences | LaunchVic |
| Adjunct Associate Professor of Mental Health | Swinburne University of Technology | Forbes Australia |
Stories naming Dr Daniel Perkins. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Melbourne-based biotech Neurala Biosciences, founded by two researchers turning DMT and harmala compounds into medicines, covering its origins, grant and investor backing totalling $4.5m, and planned first-in-human studies.
Roundup of the week's Australian raises: Sitemate, Kashcade, Psychae Therapeutics, MediCann Health, Refilled and Upworth together banked $21.3 million across software, lending, psychedelic medicine, cannabis and drink dispensing.
Also Startup Daily·Startup Daily·SmartCompany·Forbes Australia